Organon & Co. (NYSE: OGN) closed the day trading at $17.41 down -2.36% from the previous closing price of $17.83. In other words, the price has decreased by -$0.42 from its previous closing price. On the day, 2781878 shares were traded.
Ratios:
For a better understanding of OGN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.42 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.12. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.54.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on November 03, 2023, Downgraded its rating to Neutral and sets its target price to $16 from $33 previously.
On September 21, 2023, Barclays started tracking the stock assigning a Overweight rating and target price of $28.
On March 16, 2023, Raymond James started tracking the stock assigning a Outperform rating and target price of $33.Raymond James initiated its Outperform rating on March 16, 2023, with a $33 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 22 when Weaver Kirke bought 2,720 shares for $18.36 per share. The transaction valued at 49,939 led to the insider holds 15,181 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OGN now has a Market Capitalization of 4.56B and an Enterprise Value of 12.63B. As of this moment, Organon’s Price-to-Earnings (P/E) ratio for their current fiscal year is 4.36, and their Forward P/E ratio for the next fiscal year is 3.88. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.71. Its current Enterprise Value per Revenue stands at 2.02 whereas that against EBITDA is 8.79.
Stock Price History:
Over the past 52 weeks, OGN has reached a high of $24.99, while it has fallen to a 52-week low of $10.84. The 50-Day Moving Average of the stock is 16.10, while the 200-Day Moving Average is calculated to be 17.65.
Shares Statistics:
Over the past 3-months, OGN traded about 3.94M shares per day on average, while over the past 10 days, OGN traded about 3.34M shares per day. A total of 255.63M shares are outstanding, with a floating share count of 255.36M. Insiders hold about 0.11% of the company’s shares, while institutions hold 78.83% stake in the company. Shares short for OGN as of Feb 15, 2024 were 13.34M with a Short Ratio of 3.39, compared to 13.81M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.22% and a Short% of Float of 5.96%.
Dividends & Splits
OGN’s forward annual dividend rate is 1.12, up from 1.12 a year ago. Against a Trailing Annual Dividend Yield of 6.28%, it implies a Forward Annual Dividend Yield of 6.28%.
Earnings Estimates
Current recommendations for the stock of the company come from 5 analysts. On average, analysts expect EPS of $1.05 for the current quarter, with a high estimate of $1.19 and a low estimate of $0.9, while EPS last year was $1.08. The consensus estimate for the next quarter is $1.1, with high estimates of $1.15 and low estimates of $1.02.
Analysts are recommending an EPS of between $4.51 and $4.13 for the fiscal current year, implying an average EPS of $4.33. EPS for the following year is $4.53, with 7 analysts recommending between $4.73 and $4.35.
Revenue Estimates
4 analysts predict $1.57B in revenue for the current quarter. It ranges from a high estimate of $1.61B to a low estimate of $1.53B. As of the current estimate, Organon & Co.’s year-ago sales were $1.55B, an estimated increase of 1.80% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $1.63B, an increase of 3.50% over than the figure of $1.80% in the same quarter last year. There is a high estimate of $1.64B for the next quarter, whereas the lowest estimate is $1.61B.
A total of 7 analysts have provided revenue estimates for OGN’s current fiscal year. The highest revenue estimate was $6.47B, while the lowest revenue estimate was $6.32B, resulting in an average revenue estimate of $6.4B. In the same quarter a year ago, actual revenue was $6.26B, up 2.10% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $6.52B in the next fiscal year. The high estimate is $6.8B and the low estimate is $6.34B. The average revenue growth estimate for next year is up 1.90% from the average revenue estimate for this year.
